UTOLA: UTerin OLAparib

NCT03745950 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

147

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Carcinoma

Interventions

DRUG: Olaparib Oral Capsule
DRUG: Placebo oral capsule

Sponsor

ARCAGY/ GINECO GROUP